Mechanisms of resistance to CAR T cell therapy - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/30837712/

The successes with chimeric antigen receptor (CAR) T cell therapy in early clinical trials involving patients with pre-B cell acute lymphoblastic leukaemia (ALL) or B cell lymphomas have revolutionized anticancer therapy, providing a potentially curative option for patients who are refractory to sta ...